InvestorsHub Logo
Followers 0
Posts 13
Boards Moderated 0
Alias Born 08/30/2019

Re: None

Sunday, 06/28/2020 11:38:47 AM

Sunday, June 28, 2020 11:38:47 AM

Post# of 6602
In my opinion the company is still undervalued. Steady (but slow) revenue increase, new product and significant decrease in the expenses. Ekso NR is currently the best product on the market, the Vest is still a wild card and lets not forget about the established collaboration with hospitals, universities.
It will be interesting to see how the covid 19 situation disrupted the operations.
I think it will be still undervalued in short term but I dont expect any further share sale/offering in the next 12 months, the Q2 results will give some guidance on the cash burn.

Everyone is critizing Jack and the management, maybe rightfully, but they have a plan and they are going forward.

...my 2 cents
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News